Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis The New England Journal of Medicine 370 (22), 2071-2082, 2014 | 4545 | 2014 |
Riociguat for the treatment of pulmonary arterial hypertension. RLJ Ghofrani HA, Galiè N, Grimminger F, Grünig E, PS Group N Engl J Med 369 (4), 330-40, 2013 | 1597* | 2013 |
European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis SR Johnson, JF Cordier, R Lazor, V Cottin, U Costabel, S Harari, ... European Respiratory Journal 35 (1), 14-26, 2010 | 717 | 2010 |
Pulmonary hypertension in chronic lung disease and hypoxia SD Nathan, JA Barbera, SP Gaine, S Harari, FJ Martinez, H Olschewski, ... European Respiratory Journal 53 (1), 2019 | 625 | 2019 |
Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial ORTG Raghu G, Behr J, Brown KK, Egan JJ, Kawut SM, ... Ann Intern Med. 158 (9), 641-9, 2013 | 559 | 2013 |
Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals T Kustin, N Harel, U Finkel, S Perchik, S Harari, M Tahor, I Caspi, R Levy, ... Nature medicine 27 (8), 1379-1384, 2021 | 404 | 2021 |
Airway inflammation in severe chronic obstructive pulmonary disease: relationship with lung function and radiologic emphysema G Turato, R Zuin, M Miniati, S Baraldo, F Rea, B Beghé, S Monti, ... American journal of respiratory and critical care medicine 166 (1), 105-110, 2002 | 345 | 2002 |
Effects on health of air pollution: a narrative review PM Mannucci, S Harari, I Martinelli, M Franchini Internal and emergency medicine 10, 657-662, 2015 | 320 | 2015 |
Cellular interactions in the pathogenesis of interstitial lung diseases G Bagnato, S Harari European Respiratory Review 24 (135), 102-114, 2015 | 314 | 2015 |
Macitentan for the treatment of idiopathic pulmonary fibrosis: the randomised controlled MUSIC trial JBMSG Ganesh Raghu , Rachel Million-Rousseau , Adele Morganti , Lo¨ıc Perchenet DOI: 10.1183/09031936.00104612 42, 1622-1632, 2013 | 305* | 2013 |
Fibrosing interstitial lung diseases: knowns and unknowns V Cottin, L Wollin, A Fischer, M Quaresma, S Stowasser, S Harari European Respiratory Review 28 (151), 2019 | 285 | 2019 |
Formoterol mono-and combination therapy with tiotropium in patients with COPD: a 6-month study C Vogelmeier, P Kardos, S Harari, SJM Gans, S Stenglein, J Thirlwell Respiratory medicine 102 (11), 1511-1520, 2008 | 232 | 2008 |
Walking distance on 6-MWT is a prognostic factor in idiopathic pulmonary fibrosis A Caminati, A Bianchi, R Cassandro, MR Mirenda, S Harari Respiratory medicine 103 (1), 117-123, 2009 | 184 | 2009 |
Prolonged low-dose methylprednisolone in patients with severe COVID-19 pneumonia F Salton, P Confalonieri, GU Meduri, P Santus, S Harari, R Scala, S Lanini, ... Open forum infectious diseases 7 (10), ofaa421, 2020 | 168 | 2020 |
IPF: new insight on pathogenesis and treatment S Harari, A Caminati Allergy 65 (5), 537-553, 2010 | 157 | 2010 |
Classification of pulmonary neuroendocrine tumors: new insights G Pelosi, A Sonzogni, S Harari, A Albini, E Bresaola, C Marchiò, F Massa, ... Translational lung cancer research 6 (5), 513, 2017 | 149 | 2017 |
Current understanding and management of pulmonary Langerhans cell histiocytosis R Vassallo, S Harari, A Tazi Thorax 72 (10), 937-945, 2017 | 144 | 2017 |
Smoking-related interstitial pneumonias and pulmonary Langerhans cell histiocytosis A Caminati, S Harari Proceedings of the American Thoracic Society 3 (4), 299-306, 2006 | 144 | 2006 |
Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials LA Saketkoo, S Mittoo, D Huscher, D Khanna, PF Dellaripa, O Distler, ... Thorax 69 (5), 436-444, 2014 | 140 | 2014 |
International guidelines for the selection of lung transplant candidates R Aris, RG Barbers, R Barst, MA Baz, W de Boer, PA Corris, J Dark, ... American journal of respiratory and critical care medicine 158 (1), 335-339, 1998 | 140 | 1998 |